Construction and manipulation of a new Kaposi's sarcoma-associated herpesvirus bacterial artificial chromosome clone

Journal of Virology

Volumn 86, Issue 18, 2012, Pages 9708-9720

  Brulois, Kevin F ^a   Chang, Heesoon ^a,b   Lee, Amy Si Ying ^b   Ensser, Armin ^a,c   Wong, Lai Yee ^a,b   Toth, Zsolt ^a   Lee, Sun Hwa ^a   Lee, Hye Ra ^a,b   Myoung, Jinjong ^d   Ganem, Don ^d   Oh, Tae Kwang ^e   Kim, Jihyun F ^e   Gao, Shou Jiang ^a   Jung, Jae U ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^d NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^e Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CELL LINEAGE; CELL SURFACE; DOWN REGULATION; EPSTEIN BARR VIRUS; ESCHERICHIA COLI; GENE DELETION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE REARRANGEMENT; GENE REPLICATION; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN HERPESVIRUS 8; K3 GENE; K5 GENE; LYMPHOMA CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VIRUS GENE; VIRUS GENOME; VIRUS REACTIVATION;

ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; CHROMOSOMES, ARTIFICIAL, BACTERIAL; CLONING, MOLECULAR; DNA, VIRAL; ESCHERICHIA COLI; GENE DELETION; GENE EXPRESSION REGULATION, VIRAL; GENOME, VIRAL; HERPESVIRUS 8, HUMAN; HISTOCOMPATIBILITY ANTIGENS CLASS I; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMEDIATE-EARLY PROTEINS; LYMPHOMA, PRIMARY EFFUSION; MOLECULAR SEQUENCE DATA; MUTATION; PLASMIDS; VERO CELLS; VIRAL PROTEINS;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 8; MAMMALIA;

EID: 84866184336     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01019-12     Document Type: Article

References (77)

1. Adang LA, Tomescu C, Law WK, Kedes DH. 2007. Intracellular Kaposi's sarcoma-associated herpesvirus load determines early loss of immune synapse components. J. Virol. 81:5079-5090.
2. Barozzi P, et al. 2008. Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma. Transplantation 86:738-744.
3. Bartee E, Mansouri M, Nerenberg BTH, Gouveia K, Fruh K. 2004. Downregulation of major histocompatibility complex class I by human ubiquitin ligases related to viral immune evasion proteins. J. Virol. 78:1109-1120.
4. Bartee E, Mccormack A, Fruh K. 2006. Quantitative membrane proteomics reveals new cellular targets of viral immune modulators. PLoS Pathog. 2:e107. doi:10.1371/journal.ppat.0020107.
5. Bechtel J, Grundhoff A, Ganem D. 2005. RNAs in the virion of Kaposi's sarcoma-associated herpesvirus. J. Virol. 79:10138-10146.
6. Bellani M, Shlain V, Nudel C, Sanchez Rivas C. 1997. Tn1000 (gamma delta) insertions stabilize pBR322-derived recombinant plasmids in Escherichia coli. Biotechnol. Lett. 19:1-5.
7. Bihl F, et al. 2007. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma. AIDS 21:1245-1252.
8. Boname JM, Stevenson PG. 2001. MHC class I ubiquitination by a viral PHD/LAP finger protein. Immunity 15:627-636.
9. Boshoff C, et al. 1995. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat. Med. 1:1274-1278.
10. Boshoff C, Weiss R. 2002. AIDS-related malignancies. Nat. Rev. Cancer 2:373-382.
11. Budt M, Hristozova T, Hille G, Berger K, Brune W. 2011. Construction of a lytically replicating Kaposi's sarcoma-associated herpesvirus. J. Virol. 85:10415-10420.
12. Cadwell K, Coscoy L. 2005. Ubiquitination on nonlysine residues by a viral E3 ubiquitin ligase. Science 309:127-130.
13. Chang H, Dittmer DP, Shin YC, Hong Y, Jung JU. 2005. Role of Notch signal transduction in Kaposi's sarcoma-associated herpesvirus gene expression. J. Virol. 79:14371-14382.
14. Chang H, et al. 2009. Non-human primate model of Kaposi's sarcomaassociated herpesvirus infection. PLoS Pathog. 5:e1000606. doi:10.1371/journal.ppat.1000606.
15. Chaturvedi AK, Mbulaiteye SM, Engels EA. 2008. Underestimation of relative risks by standardized incidence ratios for AIDS-related cancers. Ann. Epidemiol. 18:230-234.
16. Ciufo DM, et al. 2001. Spindle cell conversion by Kaposi's sarcomaassociated herpesvirus: formation of colonies and plaques with mixed lytic and latent gene expression in infected primary dermal microvascular endothelial cell cultures. J. Virol. 75:5614-5626.
17. Coscoy L. 2007. Immune evasion by Kaposi's sarcoma-associated herpesvirus. Nat. Rev. Immunol. 7:391-401.
18. Coscoy L, Ganem D. 2000. Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display ofMHCclass I chains by enhancing their endocytosis. Proc. Natl. Acad. Sci. U. S. A. 97:8051-8056.
19. Coscoy L, Ganem D. 2001. A viral protein that selectively downregulates ICAM-1 and B7-2 and modulates T cell costimulation. J. Clin. Invest. 107:1599-1606.
20. Du MQ, Bacon CM, Isaacson PG. 2007. Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and lymphoproliferative disorders. J. Clin. Pathol. 60:1350-1357.
21. Duncan LM, et al. 2006. Lysine-63-linked ubiquitination is required for endolysosomal degradation of class I molecules. EMBO J. 25:1635-1645.
22. Durrington HJ, et al. 2010. Identification of a lysosomal pathway regulating degradation of the bone morphogenetic protein receptor type II. J. Biol. Chem. 285:37641-37649.
23. Estep RD, Powers MF, Yen BK, Li H, Wong SW. 2007. Construction of an infectious rhesus rhadinovirus bacterial artificial chromosome for the analysis of Kaposi's sarcoma-associated herpesvirus-related disease development. J. Virol. 81:2957-2969.
24. Fruh K, Bartee E, Gouveia K, Mansouri M. 2002. Immune evasion by a novel family of viral PHD/LAP-finger proteins of gamma-2 herpesviruses and poxviruses. Virus Res. 88:55-69.
25. Ganem D. 2010. KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine. J. Clin. Invest. 120:939-949.
26. Glaunsinger B, Ganem D. 2004. Lytic KSHV infection inhibits host gene expression by accelerating global mRNA turnover. Mol. Cell 13:713-723.
27. Haque M, et al. 2000. Identification and analysis of the K5 gene of Kaposi's sarcoma-associated herpesvirus. J. Virol. 74:2867-2875.
28. Haque M, et al. 2001. Major histocompatibility complex class I molecules are down-regulated at the cell surface by the K5 protein encoded by Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8. J. Gen. Virol. 82:1175-1180.
29. Harris S, Lang SM, Means RE. 2010. Characterization of the rhesus fibromatosis herpesvirus MARCH family member rfK3. Virology 398:214-223.
30. Ishido S, et al. 2000. Inhibition of natural killer cell-mediated cytotoxicity by Kaposi's sarcoma-associated herpesvirus K5 protein. Immunity 13: 365-374.
31. Ishido S, Wang C, Lee BS, Cohen GB, Jung JU. 2000. Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins. J. Virol. 74:5300-5309.
32. Jones T, et al. 2012. Direct and efficient cellular transformation of primary rat mesenchymal precursor cells by KSHV. J. Clin. Invest. 122:1076-1081.
33. Karki R, Lang SM, Means RE. 2011. The MARCH family E3 ubiquitin ligase K5 alters monocyte metabolism and proliferation through receptor tyrosine kinase modulation. PloS Pathog. 7:e1001331. doi:10.1371/journal.ppat.1001331.
34. Karlovsky P, Vaskova M. 1986. Hot spot for Tn1000 insertions in cloned repressor gene of the L phage. Plasmid 16:219-221.
35. Krishnan HH, et al. 2004. Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression. J. Virol. 78:3601-3620.
36. Lagos D, et al. 2007. Kaposi sarcoma herpesvirus-encoded vFLIP and vIRF1 regulate antigen presentation in lymphatic endothelial cells. Blood 109:1550-1558.
37. Lambert M, et al. 2006. Differences in the frequency and function of HHV8-specific CD8 T cells between asymptomatic HHV8 infection and Kaposi sarcoma. Blood 108:3871-3880.
38. Lehner PJ, Hoer S, Dodd R, Duncan LM. 2005. Downregulation of cell surface receptors by the K3 family of viral and cellular ubiquitin E3 ligases. Immunol. Rev. 207:112-125.
39. Li Q, Means R, Lang S, Jung JU. 2007. Downregulation of gamma interferon receptor 1 by Kaposi's sarcoma-associated herpesvirus K3 and K5. J. Virol. 81:2117-2127.
40. Liang C, Lee JS, Jung JU. 2008. Immune evasion in Kaposi's sarcomaassociated herpes virus associated oncogenesis. Semin. Cancer Biol. 18:423-436.
41. +T cells by targeting different endothelial proteins. J. Immunol. 184:5186-5192.
42. Mansouri M, et al. 2006. Kaposi sarcoma herpesvirus K5 removes CD31/PECAM from endothelial cells. Blood 108:1932-1940.
43. Mansouri M, Rose PP, Moses AV, Fruh K. 2008. Remodeling of endothelial adherens junctions by Kaposi's sarcoma-associated herpesvirus. J. Virol. 82:9615-9628.
44. Mansouri M, et al. 2009. Molecular mechanism of BST2/tetherin downregulation by K5/MIR2 of Kaposi's sarcoma-associated herpesvirus. J. Virol. 83:9672-9681.
45. Matthews NC, Goodier MR, Robey RC, Bower M, Gotch FM. 2011. Killing of Kaposi's sarcoma-associated herpesvirus-infected fibroblasts during latent infection by activated natural killer cells. Eur. J. Immunol. 41:1958-1968.
46. Mesri EA, Cesarman E, Boshoff C. 2010. Kaposi's sarcoma and its associated herpesvirus. Nat. Rev. Cancer 10:707-719.
47. Messerle M, Crnkovic I, Hammerschmidt W, Ziegler H, Koszinowski UH. 1997. Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome. Proc. Natl. Acad. Sci. U. S. A. 94:14759-14763.
48. Mutlu AD, et al. 2007. In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma. Cancer Cell 11:245-258.
49. Myoung J, Ganem D. 2011. Generation of a doxycycline-inducible KSHV producer cell line of endothelial origin: maintenance of tight latency with efficient reactivation upon induction. J. Virol. Methods 174:12-21.
50. Nathan JA, Lehner PJ. 2009. The trafficking and regulation of membrane receptors by the RING-CH ubiquitin E3 ligases. Exp. Cell Res. 315:1593-1600.
51. Okuno T, et al. 2002. Activation of human herpesvirus 8 open reading frame K5 independent of ORF50 expression. Virus Res. 90:77-89.
52. Parsons CH, et al. 2006. KSHV targets multiple leukocyte lineages during long-term productive infection in NOD/SCID mice. J. Clin. Invest. 116: 1963-1973.
53. Poole LJ, et al. 1999. Comparison of genetic variability at multiple loci across the genomes of the major subtypes of Kaposi's sarcoma-associated herpesvirus reveals evidence for recombination and for two distinct types of open reading frame K15 alleles at the right-hand end. J. Virol. 73:6646-6660.
54. Rhodes DA, Boyle LH, Boname JM, Lehner PJ, Trowsdale J. 2010. Ubiquitination of lysine-331 by Kaposi's sarcoma-associated herpesvirus protein K5 targets HFE for lysosomal degradation. Proc. Natl. Acad. Sci.U. S. A. 107:16240-16245.
55. Rimessi P, et al. 2001. Transcription pattern of human herpesvirus 8 open reading frame K3 in primary effusion lymphoma and Kaposi's sarcoma. J. Virol. 75:7161-7174.
56. Sanchez DJ, Coscoy L, Ganem D. 2002. Functional organization of MIR2, a novel viral regulator of selective endocytosis. J. Biol. Chem. 277:6124-6130.
57. Sanchez DJ, Gumperz JE, Ganem D. 2005. Regulation of CD1d expression and function by a herpesvirus infection. J. Clin. Invest. 115:1369-1378.
58. Shin YC, et al. 2010. Glycoprotein gene sequence variation in rhesus monkey rhadinovirus. Virology 400:175-186.
59. Stevenson PG, et al. 2002. K3-mediated evasion of CD8(+) T cells aids amplification of a latent gamma-herpesvirus. Nat. Immunol. 3:733-740.
60. Sturzl M, et al. 2009. The contribution of systems biology and reverse genetics to the understanding of Kaposi's sarcoma-associated herpesvirus pathogenesis in endothelial cells. Thromb. Haemost. 102:1117-1134.
61. Taylor JL, Bennett HN, Snyder BA, Moore PS, Chang Y. 2005. Transcriptional analysis of latent and inducible Kaposi's sarcoma-associated herpesvirus transcripts in the K4 to K7 region. J. Virol. 79:15099-15106.
62. Thomas M, et al. 2008. Down-regulation of NKG2D and NKp80 ligands by Kaposi's sarcoma-associated herpesvirus K5 protects against NK cell cytotoxicity. Proc. Natl. Acad. Sci. U. S. A. 105:1656-1661.
63. Thomas M, Wills M, Lehner PJ. 2008. Natural killer cell evasion by an E3 ubiquitin ligase from Kaposi's sarcoma-associated herpesvirus. Biochem. Soc. Trans. 36:459-463.
64. Tischer BK, Smith GA, Osterrieder N. 2010. En passant mutagenesis: a two step markerless red recombination system. Methods Mol. Biol. 634: 421-430.
65. Tischer BK, Einem J.V., Kaufer B, Osterrieder N. 2006. Two-step red-mediated recombination for versatile high-efficiency markerlessDNA manipulation in Escherichia coli. Biotechniques 40:191-197.
66. Toth Z, et al. 2010. Epigenetic analysis of KSHV latent and lytic genomes. PloS Pathog. 6:e1001013. doi:10.1371/journal.ppat.1001013.
67. Toth Z, et al. 2012. Negative elongation factor-mediated suppression of RNA polymerase II elongation of Kaposi's sarcoma-associated herpesvirus lytic gene expression. J. Virol. 86:9696-9707.
68. Tu CP, Cohen SN. 1980. Translocation specificity of the Tn3 element: characterization of sites of multiple insertions. Cell 19:151-160.
69. Vieira J, O'Hearn PM. 2004. Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression. Virology 325:225-240.
70. Warden C, Tang QY, Zhu H. 2011. Herpesvirus BACs: past, present, and future. J. Biomed. Biotechnol. 2011:124595. doi:10.1155/2011/124595.
71. Wen KW, Damania B. 2010. Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis. Cancer Lett. 289:140-150.
72. Wu W, et al. 2006. KSHV/HHV-8 infection of human hematopoietic progenitor (CD34+) cells: persistence of infection during hematopoiesis in vitro and in vivo. Blood 108:141-151.
73. Yakushko Y, et al. 2011. Kaposi's sarcoma-associated herpesvirus bacterial artificial chromosome contains a duplication of a long unique-region fragment within the terminal repeat region. J. Virol. 85:4612-4617.
74. Yoo SM, et al. 2008. Centrifugal enhancement of Kaposi's sarcomaassociated virus infection of human endothelial cells in vitro. J. Virol. Methods 154:160-166.
75. Yoo SM, Zhou FC, Ye FC, Pan HY, Gao SJ. 2005. Early and sustained expression of latent and host modulating genes in coordinated transcriptional program of KSHV productive primary infection of human primary endothelial cells. Virology 343:47-64.
76. Zhou FC, et al. 2002. Efficient infection by a recombinant Kaposi's sarcoma-associated herpesvirus cloned in a bacterial artificial chromosome: application for genetic analysis. J. Virol. 76:6185-6196.
77. Zong JC, Metroka C, Reitz MS, Nicholas J, Hayward GS. 1997. Strain variability among Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genomes: evidence that a large cohort of United States AIDS patients may have been infected by a single common isolate. J. Virol. 71:2505-2511.